{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:26:56Z","timestamp":1794878816619,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05847-x","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:18:29Z","timestamp":1757341109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Linc01271 promotes lipid synthesis and MASLD\/MASH progression via miR-149-3p\/RAB35 axis"],"prefix":"10.1007","volume":"82","author":[{"given":"Zhaoqing","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caibin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-5122","authenticated-orcid":false,"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"5847_CR1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41575-023-00868-y","volume":"20","author":"E Kotsiliti","year":"2023","unstructured":"Kotsiliti E (2023) Folate receptor-gamma in MASH-related fibrosis. Nat Rev Gastroenterol Hepatol 20:760","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5847_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/1744666X.2023.2294046","volume":"20","author":"J Schw\u00e4rzler","year":"2024","unstructured":"Schw\u00e4rzler J, Grabherr F, Grander C, Adolph TE, Tilg H (2024) The pathophysiology of MASLD: an immunometabolic perspective. Expert Rev Clin Immunol 20:375\u2013386","journal-title":"Expert Rev Clin Immunol"},{"key":"5847_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.06.016","author":"V Taru","year":"2024","unstructured":"Taru V, Szabo G, Mehal W, Reiberger T (2024) Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2024.06.016","journal-title":"J Hepatol"},{"key":"5847_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi0759","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, Friedman SL (2023) Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). Sci Transl Med 15:eadi0759","journal-title":"Sci Transl Med"},{"key":"5847_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00109-022-02248-6","volume":"100","author":"Z Yang","year":"2022","unstructured":"Yang Z, Zhang H, Yin M, Cheng Z, Jiang P, Feng M, Liu Z, Liao B (2022) TGF-beta1\/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a. J Mol Med (Berl) 100:1465\u20131478","journal-title":"J Mol Med (Berl)"},{"key":"5847_CR6","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","volume":"79","author":"AL Hutchison","year":"2023","unstructured":"Hutchison AL, Tavaglione F, Romeo S, Charlton M (2023) Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance. J Hepatol 79:1524\u20131541","journal-title":"J Hepatol"},{"key":"5847_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS (2016) Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism 65:1109\u20131123","journal-title":"Metabolism"},{"key":"5847_CR8","doi-asserted-by":"crossref","unstructured":"Nassir F (2022) NAFLD: Mechanisms, treatments, and biomarkers. Biomolecules 12","DOI":"10.3390\/biom12060824"},{"key":"5847_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S (2020) Nonalcoholic steatohepatitis: a review. JAMA 323:1175\u20131183","journal-title":"JAMA"},{"key":"5847_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","volume":"136","author":"OO Badmus","year":"2022","unstructured":"Badmus OO, Hillhouse SA, Anderson CD, Hinds TD, Stec DE (2022) Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways. Clin Sci (Lond) 136:1347\u20131366","journal-title":"Clin Sci (Lond)"},{"key":"5847_CR11","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 75:3313\u20133327","journal-title":"Cell Mol Life Sci"},{"key":"5847_CR12","doi-asserted-by":"publisher","first-page":"102569","DOI":"10.1016\/j.redox.2022.102569","volume":"59","author":"A Abulikemu","year":"2023","unstructured":"Abulikemu A, Zhao X, Xu H, Li Y, Ma R, Yao Q, Wang J, Sun Z, Li Y, Guo C (2023) Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress. Redox Biol 59:102569","journal-title":"Redox Biol"},{"key":"5847_CR13","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184:2537\u20132564","journal-title":"Cell"},{"key":"5847_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra F, Svegliati-Baroni G (2018) Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol 68:280\u2013295","journal-title":"J Hepatol"},{"key":"5847_CR15","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1016\/j.molcel.2022.09.018","volume":"82","author":"T Hou","year":"2022","unstructured":"Hou T, Tian Y, Cao Z, Zhang J, Feng T, Tao W, Sun H, Wen H, Lu X, Zhu Q, Li M, Lu X, Liu B, Zhao Y, Yang Y, Zhu WG (2022) Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation. Mol Cell 82:4099\u20134115e4099","journal-title":"Mol Cell"},{"key":"5847_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101109","volume":"83","author":"H Li","year":"2021","unstructured":"Li H, Yu XH, Ou X, Ouyang XP, Tang CK (2021) Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res 83:101109","journal-title":"Prog Lipid Res"},{"key":"5847_CR17","doi-asserted-by":"crossref","unstructured":"Simon J, Nunez-Garcia M, Fernandez-Tussy P, Barbier-Torres L, Fernandez-Ramos D, Gomez-Santos B, Buque X, Lopitz-Otsoa F, Goikoetxea-Usandizaga N, Serrano-Macia M, Rodriguez-Agudo R, Bizkarguenaga M, Zubiete-Franco I, Gutierrez-de Juan V, Cabrera D, Alonso C, Iruzubieta P, Romero-Gomez M, van Liempd S, Castro A, Nogueiras R, Varela-Rey M, Falcon-Perez JM, Villa E, Crespo J, Lu SC, Mato JM, Aspichueta P, Delgado TC, Martinez-Chantar ML (2020) Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly. Cell Metab 31:605\u2013622.e610","DOI":"10.1016\/j.cmet.2020.01.013"},{"key":"5847_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s11658-023-00492-3","volume":"28","author":"X Han","year":"2023","unstructured":"Han X, Guo B, Zhao S, Li Y, Zhu J, He Y, Wang J, Yao Q, Shao S, Zheng L, Shi Z, Han T, Hong W, Zhang K (2023) LncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization. Cell Mol Biol Lett 28:77","journal-title":"Cell Mol Biol Lett"},{"key":"5847_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.ade0522","volume":"381","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang M, Chen J, Li Y, Kuang Z, Dende C, Raj P, Quinn G, Hu Z, Srinivasan T, Hassell B, Ruhn KA, Behrendt CL, Liang T, Dou X, Song Z, Hooper LV (2023) The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9. Science 381:851\u2013857","journal-title":"Science"},{"key":"5847_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-023-02741-x","volume":"42","author":"M Ahmad","year":"2023","unstructured":"Ahmad M, Weiswald LB, Poulain L, Denoyelle C, Meryet-Figuiere M (2023) Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk. J Exp Clin Cancer Res 42:173","journal-title":"J Exp Clin Cancer Res"},{"key":"5847_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer J, Dimitrova N (2024) Transcription regulation by long non-coding rnas: mechanisms and disease relevance. Nat Rev Mol Cell Biol 25:396\u2013415","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5847_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215798","volume":"543","author":"J Yang","year":"2022","unstructured":"Yang J, Liu F, Wang Y, Qu L, Lin A (2022) LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling. Cancer Lett 543:215798","journal-title":"Cancer Lett"},{"key":"5847_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04303-5","volume":"12","author":"C Tian","year":"2021","unstructured":"Tian C, Abudoureyimu M, Lin X, Chu X, Wang R (2021) Linc-ror facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression. Cell Death Dis 12:1047","journal-title":"Cell Death Dis"},{"key":"5847_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.devcel.2013.03.002","volume":"25","author":"Y Wang","year":"2013","unstructured":"Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, Wu M, Xiong J, Guo X, Liu H (2013) Endogenous miRNA sponge lincRNA-RoR regulates Oct4, nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 25:69\u201380","journal-title":"Dev Cell"},{"key":"5847_CR25","first-page":"6868","volume":"16","author":"G Du","year":"2024","unstructured":"Du G, Jiang Z, Xia T, Liu M, Liu Z, Zhou H, Zhang H, Zhai X, Jin B (2024) lincRNA00907 promotes NASH progression by targeting miRNA-942-5p\/TAOK1. Aging 16:6868\u20136882","journal-title":"Aging"},{"key":"5847_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-024-03134-4","volume":"43","author":"Z Lin","year":"2024","unstructured":"Lin Z, Huang Z, Qiu J, Shi Y, Zuo D, Qiu Z, He W, Niu Y, Yuan Y, Li B (2024) M(6)A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma. J Exp Clin Cancer Res 43:206","journal-title":"J Exp Clin Cancer Res"},{"key":"5847_CR27","doi-asserted-by":"publisher","first-page":"10785","DOI":"10.18632\/aging.205120","volume":"15","author":"Z Xia","year":"2023","unstructured":"Xia Z, Tu R, Liu F, Zhang H, Dai Z, Wang Z, Luo P, He S, Xiao G, Feng J, Cheng Q (2023) PD-L1-related IncRNAs are associated with malignant characteristics and immune microenvironment in glioma. Aging 15:10785\u201310810","journal-title":"Aging"},{"key":"5847_CR28","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1038\/s41467-020-20207-y","volume":"11","author":"KC Chang","year":"2020","unstructured":"Chang KC, Diermeier SD, Yu AT, Brine LD, Russo S, Bhatia S, Alsudani H, Kostroff K, Bhuiya T, Brogi E, Pappin DJ, Bennett CF, Rigo F, Spector DL (2020) MaTAR25 LncRNA regulates the Tensin1 gene to impact breast cancer progression. Nat Commun 11:6438","journal-title":"Nat Commun"},{"key":"5847_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1017\/S1462399411002109","volume":"14","author":"SM Schultze","year":"2012","unstructured":"Schultze SM, Hemmings BA, Niessen M, Tschopp O (2012) PI3K\/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med 14:e1","journal-title":"Expert Rev Mol Med"},{"key":"5847_CR30","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","volume":"12","author":"H Xiao","year":"2022","unstructured":"Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z, Liu P, Liu Z, Huang H (2022) Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism. Acta Pharm Sin B 12:2887\u20132904","journal-title":"Acta Pharm Sin B"},{"key":"5847_CR31","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/D0FO02736G","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Wang T, Liu P, Yang F, Wang X, Zheng W, Sun W (2021) Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct 12:3898\u20133918","journal-title":"Food Funct"},{"key":"5847_CR32","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","volume":"14","author":"Q Ye","year":"2023","unstructured":"Ye Q, Liu Y, Zhang G, Deng H, Wang X, Tuo L, Chen C, Pan X, Wu K, Fan J, Pan Q, Wang K, Huang A, Tang N (2023) Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice. Nat Commun 14:1402","journal-title":"Nat Commun"},{"key":"5847_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of CeRNA crosstalk and competition. Nature 505:344\u2013352","journal-title":"Nature"},{"key":"5847_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137492","volume":"282","author":"MP Cai","year":"2024","unstructured":"Cai MP, Qu CL, Du MH, Wang SY, Yang GY, Chu BB, Ming SL (2024) Role of Rab35 in modulating lipid metabolism and viral entry during pseudorabies virus infection. Int J Biol Macromol 282:137492","journal-title":"Int J Biol Macromol"},{"key":"5847_CR35","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41467-020-16696-6","volume":"11","author":"L Sawade","year":"2020","unstructured":"Sawade L, Grandi F, Mignanelli M, Pati\u00f1o-L\u00f3pez G, Klinkert K, Langa-Vives F, Di Guardo R, Echard A, Bolino A, Haucke V (2020) Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth. Nat Commun 11:2835","journal-title":"Nat Commun"},{"key":"5847_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00018-024-05114-5","volume":"81","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xia T, Xia Z, Zhou H, Li Z, Wang W, Zhai X, Jin B (2024) KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3\/Akt\/mTOR pathway. Cell Mol Life Sci 81:96","journal-title":"Cell Mol Life Sci"},{"key":"5847_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1443","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Xia P, Yang Z, Liu J, Zhu Y, Huang Z, Zhang Z, Yuan Y (2023) Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box(FBXO11) -mediated heterogeneous nuclear ribonucleoprotein A2\/B1 ubiquitination and promote hepatocellular carcinoma. Clin Transl Med 13:e1443","journal-title":"Clin Transl Med"},{"key":"5847_CR38","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41467-018-03571-8","volume":"9","author":"S Corallino","year":"2018","unstructured":"Corallino S, Malinverno C, Neumann B, Tischer C, Palamidessi A, Frittoli E, Panagiotakopoulou M, Disanza A, Malet-Engra G, Nastaly P, Galli C, Luise C, Bertalot G, Pece S, Di Fiore PP, Gauthier N, Ferrari A, Maiuri P, Scita G (2018) A RAB35-p85\/PI3K axis controls oscillatory apical protrusions required for efficient chemotactic migration. Nat Commun 9:1475","journal-title":"Nat Commun"},{"key":"5847_CR39","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X (2020) Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A 117:31189\u201331197","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5847_CR40","first-page":"1769","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM (2016) Pathogenesis Nonalcoholic Steatohepatitis Gastroenterol 150:1769\u20131777","journal-title":"Pathogenesis Nonalcoholic Steatohepatitis Gastroenterol"},{"key":"5847_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL (2022) Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol 22:429\u2013443","journal-title":"Nat Rev Immunol"},{"key":"5847_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE (2018) Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol 15:349\u2013364","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5847_CR43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12967-023-04627-0","volume":"21","author":"M Myint","year":"2023","unstructured":"Myint M, Oppedisano F, De Giorgi V, Kim BM, Marincola FM, Alter HJ, Nesci S (2023) Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions. J Transl Med 21:757","journal-title":"J Transl Med"},{"key":"5847_CR44","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1038\/s41467-023-42058-z","volume":"14","author":"Y Tsuchiya","year":"2023","unstructured":"Tsuchiya Y, Seki T, Kobayashi K, Komazawa-Sakon S, Shichino S, Nishina T, Fukuhara K, Ikejima K, Nagai H, Igarashi Y, Ueha S, Oikawa A, Tsurusaki S, Yamazaki S, Nishiyama C, Mikami T, Yagita H, Okumura K, Kido T, Miyajima A, Matsushima K, Imasaka M, Araki K, Imamura T, Ohmuraya M, Tanaka M, Nakano H (2023) Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis. Nat Commun 14:6304","journal-title":"Nat Commun"},{"key":"5847_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41467-020-20303-z","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong J, Viswanathan S, Adami E, Singh BK, Chothani SP, Ng B, Lim WW, Zhou J, Tripathi M, Ko NSJ, Shekeran SG, Tan J, Lim SY, Wang M, Lio PM, Yen PM, Schafer S, Cook SA, Widjaja AA (2021) Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH. Nat Commun 12:66","journal-title":"Nat Commun"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05847-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:33:32Z","timestamp":1757486012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05847-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5847"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05847-x","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Second Hospital of Shandong University (KYLL-2023-413).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The clinical samples used in the article were approved by the Ethics Committee (KYLL-2023-413) and informed consent was obtained from patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"338"}}